Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research
		View Press Release
  
				  
					
				
					
					
				    
  
		Inventia Life Science Announces Third Dimension Grant for 3D Cell Culture Research
		View Press Release
  
				  
					
				
					
					
				    
  
		Inventia continues global expansion into the Indian market through a distribution agreement for RASTRUM™ with Biotron Healthcare PVT Ltd
		View Press Release
  
				  
					
				
					
					
				    
  
		Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery
		View Press Release
  
				  
					
				
					
					
				    
  
		Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan
		View Press Release
  
				  
					
				
					
					
				    
  
		Inventia Life Science secures NSW Government Jobs Plus support to build a brand-new manufacturing and R&D facility in Sydney
		View Press Release
  
				  
					
				
					
					
				    
  
		Inventia Life Science cements its US presence by opening its first US office and facility at The Innovation Space™ in Wilmington, Delaware
		View Press Release
  
				  
					
				
					
					
				    
  
		Inventia has been named on the 2022 AFR BOSS Most Innovative Companies List
		View Press Release
  
				  
					
				
					
					
				    
  
		Healthcare super fund HESTA directly invests in Inventia Life Science
		View Press Release
  
				  
					
				
					
					
				    
  
		Clamping down on the causes of pre-eclampsia
		View Press Release
  
				  
					
				
					
				
					
					
				
				
			